Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA

被引:36
作者
Hertoghs, KML [1 ]
Ellis, JH [1 ]
Catchpole, IR [1 ]
机构
[1] GlaxoSmithKline Med Res Ctr, Discovery Res, Dept Gene & Prot Therapeut, Stevenage SG1 2NY, Herts, England
关键词
D O I
10.1093/nar/gkg801
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The available reagents for the attachment of functional moieties to plasmid DNA are limiting. Most reagents bind plasmid DNA in a non-sequence- specific manner, with undefined stoichiometry, and affect DNA charge and delivery properties or involve chemical modifications that abolish gene expression. The design and ability of oligonucleotides (ODNs) containing locked nucleic acids (LNAs) to bind supercoiled, double-stranded plasmid DNA in a sequence-specific manner are described for the first time. The main mechanism for LNA ODNs binding plasmid DNA is demonstrated to be by strand displacement. LNA ODNs are more stably bound to plasmid DNA than similar peptide nucleic acid (PNA) 'clamps' for procedures such as particle-mediated DNA delivery (gene gun). It is shown that LNA ODNs remain associated with plasmid DNA after cationic lipid-mediated transfection into mammalian cells. LNA ODNs can bind to DNA in a sequence-specific manner so that binding does not interfere with plasmid conformation or gene expression. Attachment of CpG-based immune adjuvants to plasmid by 'hybrid' phosphorothioate-LNA ODNs induces tumour necrosis factor-alpha production in the macrophage cell line RAW264.7. This observation exemplifies an important new, controllable methodology for adding functionality to plasmids for gene delivery and DNA vaccination.
引用
收藏
页码:5817 / 5830
页数:14
相关论文
共 45 条
  • [1] Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO
  • [2] 2-U
  • [3] Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
    Bauer, S
    Kirschning, CJ
    Häcker, H
    Redecke, V
    Hausmann, S
    Akira, S
    Wagner, H
    Lipford, GB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) : 9237 - 9242
  • [4] Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design
    Braasch, DA
    Liu, YH
    Corey, DR
    [J]. NUCLEIC ACIDS RESEARCH, 2002, 30 (23) : 5160 - 5167
  • [5] Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA
    Braasch, DA
    Corey, DR
    [J]. CHEMISTRY & BIOLOGY, 2001, 8 (01): : 1 - 7
  • [6] PD-loop: A complex of duplex DNA with an oligonucleotide
    Bukanov, NO
    Demidov, VV
    Nielsen, PE
    Frank-Kamenetskii, MD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (10) : 5516 - 5520
  • [7] Butz EA, 1998, J IMMUNOL, V160, P2139
  • [8] Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems
    Cartier, R
    Reszka, R
    [J]. GENE THERAPY, 2002, 9 (03) : 157 - 167
  • [9] CATCHPOLE I, 2002, Patent No. 02102825
  • [10] Interaction of LNA oligonucleotides with MDR1 promoter
    Chernolovskaya, EL
    Koshkin, AA
    Vlassov, VV
    [J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) : 847 - 850